Company: TVRD
Filing Date: 2025-10-20
Form Type: S-1/A
Source: 0001104659-25-100896
Chunk: 232

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-20
Form: S-1/A
Chunk 232
---
that sent the Demands or filed the Complaints) reached out to counsel for the Company to discuss a potential mootness fee in connection with the supplemental disclosures filed by Cara. On August 15, 2025, the Company resolved the fee demand and the matter is now closed.

#### Other Proceedings
From time to time, the Company may be subject to legal proceedings and claims arising in the ordinary course of its business. The Company is not currently a party or aware of any proceedings that it believes will have, individually or in the aggregate, a material adverse effect on the Company’s business, financial condition or results of operations.

<div align='center'>143</div>

TABLE OF CONTENTS

MANAGEMENT Executive Officers and Directors The following table sets forth the names, ages, and positions of our executive officers and members of our board of directors (the “Board”) as of June 30, 2025:

| Name                        | ​ | ​ | Age | ​ | ​ | Position(s)                                           | ​ |
| Executive Officers          | ​ | ​ |   ​ | ​ | ​ | ​                                                     | ​ |
| Imran Alibhai, Ph.D.        | ​ | ​ |  49 | ​ | ​ | Chief Executive Officer and Director                  | ​ |
| Dan Conn, J.D., M.B.A.      | ​ | ​ |  58 | ​ | ​ | Chief Financial Officer                               | ​ |
| John Kauh, M.D.             | ​ | ​ |  52 | ​ | ​ | Chief Medical Officer                                 | ​ |
| Jeffrey Larson, Ph.D., DABT | ​ | ​ |  64 | ​ | ​ | Senior Vice President, Research & Development         | ​ |
| Yixin “Joseph” Chen, Ph.D.  | ​ | ​ |  65 | ​ | ​ | Vice President, Chemistry, Manufacturing and Controls | ​ |
| Non-Employee Directors      | ​ | ​ |   ​ | ​ | ​ | ​                                                     | ​ |
| Sujal Shah                  | ​ | ​ |  52 | ​ | ​ | Chair of the Board of Directors                       | ​ |
| Wallace Hall                | ​ | ​ |  63 | ​ | ​ | Director                                              | ​ |
| Michael S. Wyzga            | ​ | ​ |  70 | ​ | ​ | Director                                              | ​ |
| Cynthia Smith               | ​ | ​ |  56 | ​ | ​ | Director                                              | ​